Adults with ADHD show consistent deficits in iron (ferritin <30 ng/mL in 84%), vitamin D (6.5 ng/mL lower), zinc, and magnesium. Supplementing these deficiencies produces measurable symptom improvements — particularly ferritin optimization (target >50 ng/mL), vitamin D (4000 IU/day), and zinc (15–30mg). L-tyrosine shows no benefit and develops tolerance. Screen for deficiencies before supplementing; prioritize iron and vitamin D testing.
28 sources 3/4 moderate Updated 2026-04-15
A seven-compound nutraceutical protocol (Omega-3 EPA ≥60%, Saffron 30mg, SAM-e, L-Methylfolate, Zinc, Curcumin+piperine, Magnesium glycinate) has demonstrated adjunctive efficacy for anxiety and depression across multiple RCTs and meta-analyses. Omega-3 EPA (≥1g/day) reduces depressive symptoms with effect size d≈0.61 in meta-analysis; Saffron 30mg/day matches fluoxetine 20mg in multiple head-to-head RCTs (n=40–60 per study). SAM-e (800–1600mg) and L-Methylfolate (15mg) show strong evidence specifically as SSRI augmentation. This protocol is intended as an adjunct to, not replacement for, standard psychiatric care.
22 sources 4/4 strong Updated 2026-04-15
Natural interventions for attention and focus show modest but real effects — especially for non-diagnosed 'brain fog' and subclinical attention difficulties. For clinically diagnosed ADHD, medication (stimulants or atomoxetine) remains the gold standard with the strongest evidence; natural compounds are best used as adjuncts or in cases where medication is declined. The strongest-evidenced natural interventions are: Magnesium (especially in those who are deficient), L-Theanine + low-dose caffeine (best acute focus combo), Omega-3 fatty acids EPA-dominant (particularly in children), and NAC for impulsivity. Effect sizes are consistently smaller than pharmaceutical interventions.
10 sources 3/4 moderate Updated 2026-04-15
The gut-brain axis is a real, bidirectional communication system — but the psychobiotic field suffers from a critical strain-specificity problem: evidence for one strain cannot be extrapolated to another, even within the same species. The strongest human RCT evidence comes from L. rhamnosus HN001 (perinatal mood, OR 0.44), B. longum NCC3001 (IBS-related depression with fMRI confirmation), and multi-strain combinations. Omega-3 and inositol provide complementary mechanisms. This protocol layers interventions by evidence strength across 3 phases, with dietary change as the non-negotiable foundation.
7 sources 3/4 moderate Updated 2026-04-15
For women unwilling or unable to use HRT, a targeted nutraceutical stack — anchored by magnesium bisglycinate, omega-3 fatty acids, and vitamin D3+K2 — offers moderate evidence for reducing vasomotor symptoms, improving sleep quality, and stabilizing mood during the menopausal transition. Maca (Lepidium meyenii) shows promising evidence for FSH/LH modulation and hot flash reduction, particularly in early postmenopausal women. DIM (diindolylmethane) may support favorable estrogen metabolism ratios but direct symptom evidence remains limited; it requires caution in women with estrogen-sensitive conditions. No supplement replaces HRT for severe vasomotor symptoms — be honest about that limit.
16 sources 3/4 moderate Updated 2026-04-15
Postpartum depletion is near-universal: >50% of women enter the postpartum period iron-deficient, with ferritin commonly <30 μg/L; optimal target is >50 μg/L for symptom resolution. Vitamin D deficiency affects 40–80% of new mothers and requires 2000–4000 IU/day for repletion. DHA depletion at delivery averages 48–50% vs. pre-pregnancy levels and directly correlates with mood and cognitive performance. A phased 6–12 month protocol combining iron + D3/K2 + magnesium glycinate + B12/methylfolate + omega-3 DHA/EPA resolves the majority of postpartum fatigue, brain fog, and telogen effluvium within 3–6 months.
18 sources 4/4 strong Updated 2026-04-15
Systematic supplementation targeting nutrient deficiencies can significantly reduce PPD risk. Key interventions: omega-3 (EPA-dominant, 2-3g/day), ferritin optimization (>50 μg/L), vitamin D (4000-6000 IU), magnesium glycinate (300-600mg), and L. rhamnosus HN001 probiotic. A three-phase protocol (prenatal → critical postpartum → extended) addresses the neurobiological cascade triggered by postpartum hormone collapse.
47 sources 4/4 strong Updated 2026-04-13